+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Continuous Glucose Monitors Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

  • PDF Icon

    Report

  • 151 Pages
  • December 2023
  • Region: Global
  • GlobalData
  • ID: 5917777
The Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Continuous glucose monitoring system is used for the continuous measurement of blood glucose.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Continuous Glucose Monitors under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Continuous Glucose Monitors under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Continuous Glucose Monitors Overview
3 Products under Development
3.1 Continuous Glucose Monitors - Pipeline Products by Stage of Development
3.2 Continuous Glucose Monitors - Pipeline Products by Territory
3.3 Continuous Glucose Monitors - Pipeline Products by Regulatory Path
3.4 Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
3.5 Continuous Glucose Monitors - Ongoing Clinical Trials
4 Continuous Glucose Monitors - Pipeline Products under Development by Companies
4.1 Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitors - Pipeline Products by Stage of Development
5 Continuous Glucose Monitors Companies and Product Overview6 Continuous Glucose Monitors - Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Continuous Glucose Monitors - Pipeline Products by Stage of Development
  • Continuous Glucose Monitors - Pipeline Products by Territory
  • Continuous Glucose Monitors - Pipeline Products by Regulatory Path
  • Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
  • Continuous Glucose Monitors - Ongoing Clinical Trials
  • Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
  • Continuous Glucose Monitors - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Continuous Glucose Monitors - Pipeline Products by Stage of Development
  • Continuous Glucose Monitors - Pipeline Products by Territory
  • Continuous Glucose Monitors - Pipeline Products by Regulatory Path
  • Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
  • Continuous Glucose Monitors - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Diabetes Care Inc
  • Advanced Biosensors-Ohio LLC
  • Advanced Medical Electronics Corp
  • Apollon Inc
  • Arkal Medical Inc (Inactive)
  • Azurite Technologies, Inc. (Inactive)
  • Biovotion AG
  • CALISTO MEDICAL, INC. (Inactive)
  • CGM3 Ltd
  • City, University of London
  • Columbia University
  • ConvaTec Group Plc
  • Cyber Medical Ltd (Inactive)
  • DexCom Inc
  • Echo Therapeutics Inc
  • eLutions Integrated Systems, Inc.
  • Flowsion A/S
  • Gili Medical Ltd
  • Globe Medical Tech Inc (Inactive)
  • GlucoLight Corporation (Inactive)
  • Glucometrix AG
  • Glucosense Diagnostics Ltd (Inactive)
  • GlucoTrack Inc
  • GluMetrics Inc
  • Glusense Ltd
  • GlySens Inc
  • Guided Therapeutics Inc
  • Hagar Tech
  • iGlyko, Inc. (Inactive)
  • Innovosens AB
  • Invivosense ASA (Inactive)
  • I-Sens Inc
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd
  • Know Labs Inc
  • KTH Royal Institute of Technology
  • LEMM Technologies, LLC
  • Medical Wireless Sensing Ltd
  • Medtronic MiniMed Inc
  • Metronom Health Inc
  • MicroTech Medical Co Ltd
  • mobiLIFE
  • Nemaura Medical Inc
  • Newton Photonics Inc
  • Northwestern University
  • PKvitality SAS
  • Purdue University
  • SD Biosensor Inc
  • SensiVida Medical Technologies, Inc. (Inactive)
  • Socrates Health Solutions, Inc.
  • Stony Brook University
  • Swansea University
  • Tandem Diabetes Care Inc
  • Tenax Therapeutics Inc
  • Texas A&M University
  • Ultradian Diagnostics LLC
  • University of California Berkeley
  • University of California Irvine
  • University of California San Diego
  • University of South Carolina
  • University of South Florida
  • University of Technology Sydney
  • University of Texas at Arlington
  • Uxn Co Ltd
  • VeriTeQ Corporation